Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enzymatically Polymerized Glycolated Conductive Polymers as Soft Electrodes for Neural Bioelectronic Interfaces.

ACS applied materials & interfaces·2026
Same author

Fumarate dramatically enhances biocurrent output in Shewanella-based bioelectrochemical system.

Bioelectrochemistry (Amsterdam, Netherlands)·2026
Same author

An organic artificial cardiomyocyte.

Nature communications·2026
Same author

Suspension polymerization of bioelectronic interfaces on living cells.

Materials horizons·2026
Same author

Iontronic click-to-release enables electrically controlled delivery of drugs and biomolecules beyond charge and size limitations.

Nature communications·2026
Same author

Alzheimer's disease therapy: Neurotrophin-based regenerative approaches.

Neural regeneration research·2026

Related Experiment Video

Updated: Mar 29, 2026

Flexible Organic Electronic Devices for Pulsed Electric Field Therapy of Glioblastoma
11:02

Flexible Organic Electronic Devices for Pulsed Electric Field Therapy of Glioblastoma

Published on: August 9, 2022

3.7K

Therapy using implanted organic bioelectronics.

Amanda Jonsson1, Zhiyang Song2, David Nilsson3

  • 1Laboratory of Organic Electronics, Department of Science and Technology, Linköping University, SE-601 74 Norrköping, Sweden.

Science Advances
|November 25, 2015
PubMed
Summary
This summary is machine-generated.

Researchers developed an implantable device using conducting polymers for localized drug delivery. This organic electronic system effectively treated neuropathic pain in rats by delivering gamma-aminobutyric acid (GABA) with minimal side effects.

Keywords:
Drug deliveryOrganic bioelectronicsconducting polymersin vivoneuropathic painpolyelectrolytesspinal cordtherapeutic

More Related Videos

Bidirectional Electrical and Optoelectronic Interfaces in Healthy and Ischemic Ex Vivo Rat Hearts
08:33

Bidirectional Electrical and Optoelectronic Interfaces in Healthy and Ischemic Ex Vivo Rat Hearts

Published on: July 18, 2025

1.0K
Bioinspired Soft Robot with Incorporated Microelectrodes
08:24

Bioinspired Soft Robot with Incorporated Microelectrodes

Published on: February 28, 2020

9.5K

Related Experiment Videos

Last Updated: Mar 29, 2026

Flexible Organic Electronic Devices for Pulsed Electric Field Therapy of Glioblastoma
11:02

Flexible Organic Electronic Devices for Pulsed Electric Field Therapy of Glioblastoma

Published on: August 9, 2022

3.7K
Bidirectional Electrical and Optoelectronic Interfaces in Healthy and Ischemic Ex Vivo Rat Hearts
08:33

Bidirectional Electrical and Optoelectronic Interfaces in Healthy and Ischemic Ex Vivo Rat Hearts

Published on: July 18, 2025

1.0K
Bioinspired Soft Robot with Incorporated Microelectrodes
08:24

Bioinspired Soft Robot with Incorporated Microelectrodes

Published on: February 28, 2020

9.5K

Area of Science:

  • Bioelectronic Medicine
  • Materials Science
  • Neuroscience

Background:

  • Systemic drug administration often causes side effects due to widespread distribution.
  • Localized drug delivery from implanted devices offers a potential solution for targeted therapy.
  • Conducting polymers enable bioelectronic interfaces for controlled therapeutic release.

Purpose of the Study:

  • To demonstrate the efficacy of an implantable organic electronic device for localized therapeutic delivery.
  • To investigate the potential of electrically controlled drug release for treating neuropathic pain.
  • To establish a proof-of-concept for bioelectronic therapeutics in awake animal models.

Main Methods:

  • Implantation of organic electronic devices onto the spinal cord of rats.
  • Electrically controlled local delivery of gamma-aminobutyric acid (GABA).
  • Assessment of pain response and side effects in an animal model of neuropathic pain.

Main Results:

  • Significant reduction in neuropathic pain response observed with localized GABA delivery.
  • Low dosage of GABA was effective, indicating high therapeutic efficiency.
  • No observable side effects were reported, highlighting the safety of localized delivery.

Conclusions:

  • Implantable organic electronic devices offer a viable approach for localized, electrically controlled drug delivery.
  • This technology presents a promising alternative to conventional treatments for neuropathic pain.
  • The study paves the way for future bioelectronic therapeutic applications in awake subjects.